González-Núnez, M., Munoz-Félix, J.M. and López-Novoa, J.M. (2013) The ALK-1/Smad1 Pathway in Cardiovascular Physiopathology. A New Target for Therapy? Biochimica et Biophysica Acta, 1832, 1492-1510.
http://dx.doi.org/10.1016/j.bbadis.2013.05.016

has been cited by the following article:

• TITLE: Novel ACLV1 Mutation Identified in Late Onset Hereditary Hemorrhagic Telangiectasia

  AUTHORS: Cory Patrick, Kaitlin McIntyre, Jeremy Ramidial, Sano Joa, Vijaykumar Dinsukhlal Zaveri, Damien Hansra

  KEYWORDS: Hereditary Hemorrhagic Telaniectasia, Osler-Weber-Rendu Syndrome, Anemia, Mutation

  JOURNAL NAME: International Journal of Otolaryngology and Head & Neck Surgery, Vol.5 No.4, July 18, 2016

  ABSTRACT: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disorder with variable expressivity. We present a 62-year-old patient with a rare, late-onset disease course featuring a novel mutation in ACVRL1, a signal transducer in the TGFβ/BMP pathway.